ACXP Latest Headlines

Most and least shorted healthcare stocks with up to $2B market cap in March

at seekingalpha.com (Fri, 3-Apr 8:20 AM)

Acurx Pharmaceuticals Cuts Losses and Advances Clinical Trials: New Patent and Phase 3 Planning Highlight a Pivotal Year

Market Chameleon (Mon, 16-Mar 10:29 AM)

ACXP Advances Groundbreaking Antibiotic Program with Lower R&D Spend and Solid Cash Position

Market Chameleon (Fri, 13-Mar 7:29 AM)

Acurx’s Groundbreaking Ibezapolstat Trial Targets Both Treatment and Prevention of Recurrent C. difficile Infection

Market Chameleon (Tue, 10-Mar 10:29 AM)